SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-22-059692
Filing Date
2022-09-28
Accepted
2022-09-28 13:34:29
Documents
17
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2022a1_inmedpharma.htm   iXBRL 10-K/A 70540
2 DESCRIPTION OF SECURITIES OF INMED PHARMACEUTICALS INC f10k2022a1ex4-13_inmedpharma.htm EX-4.13 7624
3 CONSULTING AGREEMENT DATED AS OF APRIL 1, 2022, BETWEEN INMED PHARMACEUTICALS IN f10k2022a1ex10-13_inmedpharm.htm EX-10.13 42704
4 CERTIFICATION f10k2022a1ex31-3_inmedpharma.htm EX-31.3 3534
5 CERTIFICATION f10k2022a1ex31-4_inmedpharma.htm EX-31.4 3524
  Complete submission text file 0001213900-22-059692.txt   368671

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inm-20220630.xsd EX-101.SCH 3280
7 XBRL DEFINITION FILE inm-20220630_def.xml EX-101.DEF 16922
8 XBRL LABEL FILE inm-20220630_lab.xml EX-101.LAB 34684
9 XBRL PRESENTATION FILE inm-20220630_pre.xml EX-101.PRE 17979
11 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022a1_inmedpharma_htm.xml XML 6675
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-39685 | Film No.: 221274691
SIC: 2834 Pharmaceutical Preparations